Confirming you are not from the U.S. or the Philippines

By giving this statement, I explicitly declare and confirm that:
  • I am not a U.S. citizen or resident
  • I am not a resident of the Philippines
  • I do not directly or indirectly own more than 10% of shares/voting rights/interest of the U.S. residents and/or do not control U.S. citizens or residents by other means
  • I am not under the direct or indirect ownership of more than 10% of shares/voting rights/interest and/or under the control of U.S. citizen or resident exercised by other means
  • I am not affiliated with U.S. citizens or residents in terms of Section 1504(a) of FATCA
  • I am aware of my liability for making a false declaration.
For the purposes of this statement, all U.S. dependent countries and territories are equalled to the main territory of the USA. I accept full responsibility for the accuracy of this declaration and commit to personally address and resolve any claims or issues that may arise from a breach of this statement.
We are dedicated to your privacy and the security of your personal information. We only collect emails to provide special offers and important information about our products and services. By submitting your email address, you agree to receive such letters from us. If you want to unsubscribe or have any questions or concerns, write to our Customer Support.
Octa trading broker
Open trading account
Test

Important information

By using this website, you confirm you are not a resident of the European Union, the United States of America, the United Kingdom, Iran, Myanmar, North Korea, Norway, Iceland, Switzerland, Liechtenstein, and the Philippines or accessing it from these jurisdictions. We assume no liability for the consequences of non-compliance with local laws.

Back

S&P 500 Futures: Tests 3,500 after Pharmamar says Aplidin drug is enormously promising in treating COVID-19

With the global COVID-19 count topping 40 million, amid the latest surge in the European coronavirus cases, Spanish pharmaceutical company PharmaMar came out with a welcome news, citing that its cancer drug - Aplidin is enormously promising in treating COVID-19.

 

more to come ...

EUR/GBP Price Analysis: Struggles near 100-DMA, around 0.9030 region

The EUR/GBP cross witnessed some heavy selling on Monday and extended the previous session's rejection slide from a resistance marked by the top end o
Read more Previous

US Elections: Blue Wave to extend USD decline and equities rally – Westpac

The outcome of the presidential election and the composition of Congress will have material implications for fiscal policy, the economic outlook and m
Read more Next